Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052
Main Author: | |
---|---|
Publication Date: | 2021 |
Other Authors: | , , , , , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da FIOCRUZ (ARCA) |
DOI: | 10.1177/09564624211030368 |
Download full: | https://arca.fiocruz.br/handle/icict/50713 |
Summary: | UNC Project-Malawi, Lilongwe. Malawi / Department of Medicine, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA. |
id |
CRUZ_ee849f7eeecea6462ecb089f15b96eba |
---|---|
oai_identifier_str |
oai:arca.fiocruz.br:icict/50713 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Chagomerana, Maganizo B.Hosseinipour, Mina C.Pilotto, José HenriqueBadal-Faesen, SharlaaNyirenda, MulindaShava, EmilyGodbole, Sheela V.Akelo, VictorChariyalertsak, SuwatPanchia, RavindreCohen, Myron2022-01-10T18:45:29Z2022-01-10T18:45:29Z2021CHAGOMERANA, Maganizo B. et al. Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052. International Journal of STD & AIDS, v. 32, n. 13, p. 1204-1211, 2021.0956-4624https://arca.fiocruz.br/handle/icict/5071310.1177/095646242110303681758-1052engSAGE PublicationsTerapia anti-retroviralHeterossexualSífilis (Treponema pallidum)Gonorreia (Neisseria gonorrhoeae)Antiretroviral therapyHeterosexualSyphilis (Treponema pallidum)Gonorrhea (Neisseria gonorrhoeae)Chlamydia (Chlamydia trachomatis)Clamídia (Chlamydia trachomatis)Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUNC Project-Malawi, Lilongwe. Malawi / Department of Medicine, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA.UNC Project-Malawi, Lilongwe. Malawi / Department of Medicine, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA.Hospital Geral de Nova Iguaçu. Nova Iguaçu, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratorio de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.Clinical HIV Research Unit, Faculty of Health Sciences, University of the WitwatersrandClinical HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand. Johannesburg, South Africa. Johannesburg, South AfricaJohns Hopkins Project, University of Malawi College of Medicine. Blantyre, Malawi.Botswana Harvard Aids Institute Partnership. Gaborone, Botswana.CMR-National AIDS Research Institute. Pune, India.Kenya Medical Research Institute (KEMRI). Nairobi, Kenya.Research Institute for Health Sciences, Chiang Mai University. Chiang Mai, Thailand / Faculty of Public Health, Chiang Mai University. Suthep, Thailand.Perinatal HIV Research Unit, University of the Witwatersrand, Soweto HPTN CRS. Soweto, South Africa.Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. NC, USA.Sexually transmitted infections (STIs) remain a public health concern because of their interaction(s) with HIV. In the HPTN 052 study, STIs were evaluated in both HIV-positive index cases and their HIV-negative partners at enrollment and at yearly follow-up visits. Our definition for STI was based on any infection with Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, or Trichomonas vaginalis. We used log-binomial regression models to identify factors associated with prevalent STIs. Generalized estimating equation models with the Poisson distribution were used to compare STI incidence between HIVpositive index cases and HIV-negative partners. 8.1% of the participants had STIs at enrollment. The prevalence of STIs (8.9 vs. 7.2) was higher in HIV-positive index cases than HIV-negative partners. Being female (prevalence ratio (PR) = 1.61; 95% CI: 1.20–2.16) or unmarried (PR = 1.92; 95% CI: 1.17–3.14) was associated with prevalent STIs. Compared to HIV-negative male partners, HIV-positive female index cases had a higher risk of STI acquisition (incidence rate ratio (IRR) = 2.25; 95% CI: 1.70–2.97). While we are implementing HIV prevention interventions for HIV-negative people, we should also intensify targeted STI prevention interventions, especially among HIV-positive women.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://arca.fiocruz.br/bitstreams/f9ddaa15-d441-44e1-801a-523ae4209e14/download5a560609d32a3863062d77ff32785d58MD51falseAnonymousREADORIGINALJoseHenrique_Pilotto_etal_IOC_2021.pdfJoseHenrique_Pilotto_etal_IOC_2021.pdfapplication/pdf717528https://arca.fiocruz.br/bitstreams/d8476705-dc52-427a-822b-53f18454264d/download12a3e87b9dca292b52d36f802a06348fMD52trueAnonymousREADTEXTJoseHenrique_Pilotto_etal_IOC_2021.pdf.txtJoseHenrique_Pilotto_etal_IOC_2021.pdf.txtExtracted texttext/plain37204https://arca.fiocruz.br/bitstreams/5f398d2a-172e-4754-a55c-a574d93d29ea/download691f14cee2444b38f9a9d84e7c15c58fMD55falseAnonymousREADTHUMBNAILJoseHenrique_Pilotto_etal_IOC_2021.pdf.jpgJoseHenrique_Pilotto_etal_IOC_2021.pdf.jpgGenerated Thumbnailimage/jpeg6230https://arca.fiocruz.br/bitstreams/0c5f35ec-b43b-4963-9cba-d03ad0e08847/download552c57aa277a84a2817480ef07ea13caMD56falseAnonymousREADicict/507132025-07-31 13:24:36.77open.accessoai:arca.fiocruz.br:icict/50713https://arca.fiocruz.brRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352025-07-31T16:24:36Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)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 |
dc.title.none.fl_str_mv |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 |
title |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 |
spellingShingle |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 Chagomerana, Maganizo B. Terapia anti-retroviral Heterossexual Sífilis (Treponema pallidum) Gonorreia (Neisseria gonorrhoeae) Antiretroviral therapy Heterosexual Syphilis (Treponema pallidum) Gonorrhea (Neisseria gonorrhoeae) Chlamydia (Chlamydia trachomatis) Clamídia (Chlamydia trachomatis) |
title_short |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 |
title_full |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 |
title_fullStr |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 |
title_full_unstemmed |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 |
title_sort |
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052 |
author |
Chagomerana, Maganizo B. |
author_facet |
Chagomerana, Maganizo B. Hosseinipour, Mina C. Pilotto, José Henrique Badal-Faesen, Sharlaa Nyirenda, Mulinda Shava, Emily Godbole, Sheela V. Akelo, Victor Chariyalertsak, Suwat Panchia, Ravindre Cohen, Myron |
author_role |
author |
author2 |
Hosseinipour, Mina C. Pilotto, José Henrique Badal-Faesen, Sharlaa Nyirenda, Mulinda Shava, Emily Godbole, Sheela V. Akelo, Victor Chariyalertsak, Suwat Panchia, Ravindre Cohen, Myron |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Chagomerana, Maganizo B. Hosseinipour, Mina C. Pilotto, José Henrique Badal-Faesen, Sharlaa Nyirenda, Mulinda Shava, Emily Godbole, Sheela V. Akelo, Victor Chariyalertsak, Suwat Panchia, Ravindre Cohen, Myron |
dc.subject.other.none.fl_str_mv |
Terapia anti-retroviral Heterossexual Sífilis (Treponema pallidum) Gonorreia (Neisseria gonorrhoeae) |
topic |
Terapia anti-retroviral Heterossexual Sífilis (Treponema pallidum) Gonorreia (Neisseria gonorrhoeae) Antiretroviral therapy Heterosexual Syphilis (Treponema pallidum) Gonorrhea (Neisseria gonorrhoeae) Chlamydia (Chlamydia trachomatis) Clamídia (Chlamydia trachomatis) |
dc.subject.en.none.fl_str_mv |
Antiretroviral therapy Heterosexual Syphilis (Treponema pallidum) Gonorrhea (Neisseria gonorrhoeae) Chlamydia (Chlamydia trachomatis) Clamídia (Chlamydia trachomatis) |
description |
UNC Project-Malawi, Lilongwe. Malawi / Department of Medicine, University of North Carolina at Chapel Hill. Chapel Hill, NC, USA. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021 |
dc.date.accessioned.fl_str_mv |
2022-01-10T18:45:29Z |
dc.date.available.fl_str_mv |
2022-01-10T18:45:29Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
CHAGOMERANA, Maganizo B. et al. Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052. International Journal of STD & AIDS, v. 32, n. 13, p. 1204-1211, 2021. |
dc.identifier.uri.fl_str_mv |
https://arca.fiocruz.br/handle/icict/50713 |
dc.identifier.issn.none.fl_str_mv |
0956-4624 |
dc.identifier.doi.none.fl_str_mv |
10.1177/09564624211030368 |
dc.identifier.eissn.none.fl_str_mv |
1758-1052 |
identifier_str_mv |
CHAGOMERANA, Maganizo B. et al. Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052. International Journal of STD & AIDS, v. 32, n. 13, p. 1204-1211, 2021. 0956-4624 10.1177/09564624211030368 1758-1052 |
url |
https://arca.fiocruz.br/handle/icict/50713 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
SAGE Publications |
publisher.none.fl_str_mv |
SAGE Publications |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://arca.fiocruz.br/bitstreams/f9ddaa15-d441-44e1-801a-523ae4209e14/download https://arca.fiocruz.br/bitstreams/d8476705-dc52-427a-822b-53f18454264d/download https://arca.fiocruz.br/bitstreams/5f398d2a-172e-4754-a55c-a574d93d29ea/download https://arca.fiocruz.br/bitstreams/0c5f35ec-b43b-4963-9cba-d03ad0e08847/download |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 12a3e87b9dca292b52d36f802a06348f 691f14cee2444b38f9a9d84e7c15c58f 552c57aa277a84a2817480ef07ea13ca |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1839716000502644736 |